Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: University of Washington
Condition: Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer
NCT00466752
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.